Clinical Trial Update: 5-HT3 Receptor Antagonist and Respiratory Drive in Patients With ARDS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating a 5-HT3 receptor antagonist and its effect on respiratory drive in patients with acute respiratory distress syndrome (ARDS)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Drugs mentioned

• 5-HT3 receptor antagonist (5-HT3 receptor antagonist)

Snippet

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Conditions: Acute Respiratory Distress Syndrome | Phase 4 | Status: UNKNOWN